Experts highlight the future of heart failure management.
This is a video synopsis/summary of a panel discussion involving Robert Groves, MD; Eugene E. Wright Jr, MD; Nancy Albert, PhD, CCNS, CCRN, CHFN, NE-BC, FAHA, FCCM, FHFSA, FAAN; Nihar Desai, MD, MPH; and Kelly Marie Axsom, MD.
When asked about the future of heart failure management, Desai says he is excited about better phenotyping beyond ejection fraction to personalize care. Grovesnotes this complexity reinforces the need for collaborative, integrative care models. Albert looks forward to disruptive innovations such as devices putting control in patients’ hands, such as glucose monitors in diabetes. Axsom envisions remote monitoring technology empowering self-management. Wright would like research on biomarkers predicting heart failure progression rates to guide treatment intensity. Groves stresses addressing social determinants such as nutrition that influence life outside healthcare visits. Asking where patients shop for food provides insights. In summary, the future of heart failure care involves better phenotyping, disruptive technologies, remote monitoring, risk stratification tools, and addressing social needs, all aimed at optimizing outcomes through individualized, patient-centered care.
Video synopsis is AI-generated and reviewed by AJMC editorial staff.
Diagnostic Oversights Limit Luspatercept Benefits in MDS
May 8th 2024Investigators of a retrospective study encourage colleagues to utilize molecular testing for patients with an established diagnosis of lower-risk myelodysplastic syndromes (MDS), to be sure they don’t miss out on treatments, like luspatercept, for which they qualify.
Read More
Coexistence of HIV, Hemophilia May Lead to Increased Presence of Coronary Artery Stenosis
May 8th 2024In patients living with HIV, the cardiovascular risk factors that come with infection may lead to an increased prevalence of coronary artery stenosis, especially in those who also have hemophilia.
Read More